| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2603 | |||||||||||||||||||||||
| Submitter : | Mrs. Andrea Kaderlik | Date & Time: | 12/05/2006 11:12:57 | |||||||||||||||||||||
| Organization : | Mrs. Andrea Kaderlik | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I am writing to state my absolute opposition to the creation and/or use of aborted fetal cell line products. This is heartbreaking to hear that we, as a society, would use (or even think of using) our most vulnerable, in such a manner. The end does not justify the means.
Sincerely, Mrs. Andrea Kaderlik | ||||||||||||||||||||||||